Article

10 Reasons Formulation Complexity Is On The Rise In Steriles

iStock-1207060947-glove-test-lab

Complexity is rising in sterile injectables, driven by factors that include, but are not limited to, formulation and delivery.

Reduce complexity and save time on the way to IND authorization and first-in-human trials.

1. Despite orphan drugs being notorious for their high costs and risk factors, the market is projected to grow at 13% CAGR from 2020-20241,2. One driver of this growth is the financial incentives and benefits companies are receiving for new biologics that pertain to orphan drugs.

2. Prior to the COVID-19 Pandemic, the global mRNA therapeutics market was estimated to reach ~3B by 20262. Complex formulations that deliver mRNA or DNA using lipid nanoparticles are on the rise. These formulations behave like oil and water emulsions, which increases complexity in formulation as well as compounding.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: